Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans

Genomics

Volumn 96, Issue 4, 2010, Pages 211-219

  Lewis, Joshua P ^a   Palmer, Nicholette D ^a   Ellington, Jennifer B ^a   Divers, Jasmin ^a   Ng, Maggie C Y ^a   Lu, Lingyi ^a   Langefeld, Carl D ^a   Freedman, Barry I ^a   Bowden, Donald W ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Adiposity; Association; Genetics; Mediation analysis; Type 2 diabetes

Indexed keywords

CARRIER PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE DEPENDENT RAC EXCHANGER 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CHROMOSOME 20Q; CONTROLLED STUDY; EUROPEAN AMERICAN; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPOSITY; AMERICAS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 20; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; KIDNEY FAILURE, CHRONIC; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77956879227     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2010.07.006     Document Type: Article

References (49)

1. Bowden D.W., Sale M., Howard T.D., Qadri A., Spray B.J., Rothschild C.B., et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 1997, 46(5):882-886.
2. Ji L., Malecki M., Warram J.H., Yang Y., Rich S.S., Krolewski A.S. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997, 46(5):876-881.
3. Zouali H., Hani E.H., Philippi A., Vionnet N., Beckmann J.S., Demenais F., et al. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum. Mol. Genet. 1997, 6(9):1401-1408.
4. Ghosh S., Watanabe R.M., Hauser E.R., Valle T., Magnuson V.L., Erdos M.R., et al. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc. Natl Acad. Sci. USA 1999, 96(5):2198-2203.
5. Klupa T., Malecki M.T., Pezzolesi M., Ji L., Curtis S., Langefeld C.D., et al. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2. Diabetes 2000, 49(12):2212-2216.
6. Permutt M.A., Wasson J.C., Suarez B.K., Lin J., Thomas J., Meyer J., et al. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 2001, 50(3):681-685.
7. Luo T.H., Zhao Y., Li G., Yuan W.T., Zhao J.J., Chen J.L., et al. A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 2001, 44(4):501-506.
8. Mori Y., Otabe S., Dina C., Yasuda K., Populaire C., Lecoeur C., et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002, 51(4):1247-1255.
9. Love-Gregory L.D., Wasson J., Ma J., Jin C.H., Glaser B., Suarez B.K., et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi jewish population. Diabetes 2004, 53(4):1134-1140.
10. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 2004, 53(4):1141-1149.
11. Weedon M.N., Owen K.R., Shields B., Hitman G., Walker M., McCarthy M.I., et al. Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. population. Diabetes 2004, 53(11):3002-3006.
12. Wanic K., Malecki M.T., Wolkow P.P., Klupa T., Skupien J., Bobrek J., et al. Polymorphisms in the gene encoding hepatocyte nuclear factor-4alpha and susceptibility to type 2 diabetes in a Polish population. Diabetes Metab. 2006, 32(1):86-88.
13. Traurig M., Hanson R.L., Kobes S., Bogardus C., Baier L.J. Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians. Diabetologia 2007, 50(5):985-989.
14. Bento J.L., Bowden D.W., Mychaleckyj J.C., Hirakawa S., Rich S.S., Freedman B.I., et al. Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. BMC Med. Genet. 2005, 6:42.
15. Florez J.C., Agapakis C.M., Burtt N.P., Sun M., Almgren P., Rastam L., et al. Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7, 883 people. Diabetes 2005, 54(6):1884-1891.
16. Spencer-Jones N.J., Wang X., Snieder H., Spector T.D., Carter N.D., O'Dell S.D. Protein tyrosine phosphatase-1B gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 2005, 54(11):3296-3304.
17. Bento J.L., Palmer N.D., Zhong M., Roh B., Lewis J.P., Wing M.R., et al. Heterogeneity in gene loci associated with type 2 diabetes on human chromosome 20q13.1. Genomics 2008, 92(4):226-234.
18. Yu H., Bowden D.W., Spray B.J., Rich S.S., Freedman B.I. Identification of human plasma kallikrein gene polymorphisms and evaluation of their role in end-stage renal disease. Hypertension 1998, 31(4):906-911.
19. Freedman B.I., Yu H., Anderson P.J., Roh B.H., Rich S.S., Bowden D.W. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol. Dial. Transplant. 2000, 15(11):1794-1800.
20. Sale M.M., Freedman B.I., Langefeld C.D., Williams A.H., Hicks P.J., Colicigno C.J., et al. A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q. Diabetes 2004, 53(3):830-837.
21. Wagenknecht L.E., Bowden D.W., Carr J.J., Langefeld C.D., Freedman B.I., Rich S.S. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001, 50(4):861-866.
22. Buetow K.H., Edmonson M., MacDonald R., Clifford R., Yip P., Kelley J., et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc. Natl Acad. Sci. USA 2001, 98(2):581-584.
23. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21(2):263-265.
24. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
25. Matarin M., Brown W.M., Scholz S., Simon-Sanchez J., Fung H.C., Hernandez D., et al. A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol. 2007, 6(5):414-420.
26. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81(3):559-575.
27. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51(6):1173-1182.
28. MacKinnon D.P., Dwyer J.H. Estimating Mediated Effects in Prevention Studies. Eval. Rev. 1993, 17:144-158.
29. MacKinnon D.P., Fairchild A.J., Fritz M.S. Mediation analysis. Annu. Rev. Psychol. 2007, 58:593-614.
30. Sobel M. Asymptotic intervals for indirect effects in structural equations models. Sociological methodology 1982, Jossey-Bass, San Francisco, CA.
31. Jasti S., Dudley W.N., Goldwater E. SAS macros for testing statistical mediation in data with binary mediators or outcomes. Nurs. Res. 2008, 57(2):118-122.
32. Goodman L. On the exact variance of products. J. Am. Stat. Assoc. 1960, 55:708-713.
33. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res. 2002, 12(6):996-1006.
34. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316(5829):1331-1336.
35. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316(5829):1341-1345.
36. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445(7130):881-885.
37. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316(5829):1336-1341.
38. WTCCC, Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678.
39. Sallinen R., Tornberg J., Putkiranta M., Horelli-Kuitunen N., Airaksinen M.S., Wessman M. Chromosomal localization of SLC12A5/Slc12a5, the human and mouse genes for the neuron-specific K(+)-Cl(-) cotransporter (KCC2) defines a new region of conserved homology. Cytogenet. Cell Genet. 2001, 94(1-2):67-70.
40. Sauve F., McBroom L.D., Gallant J., Moraitis A.N., Labrie F., Giguere V. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant. Mol. Cell. Biol. 2001, 21(1):343-353.
41. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl Acad. Sci. USA 2000, 97(23):12729-12734.
42. Sugimoto K., Honda S., Yamamoto T., Ueki T., Monden M., Kaji A., et al. Molecular cloning and characterization of a newly identified member of the cadherin family. PB-cadherin. J Biol Chem 1996, 271(19):11548-11556.
43. Welch H.C., Coadwell W.J., Ellson C.D., Ferguson G.J., Andrews S.R., Erdjument-Bromage H., et al. P-Rex1, a PtdIns(3, 4, 5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002, 108(6):809-821.
44. Hill K., Krugmann S., Andrews S.R., Coadwell W.J., Finan P., Welch H.C., et al. Regulation of P-Rex1 by phosphatidylinositol (3, 4, 5)-trisphosphate and Gbetagamma subunits. J. Biol. Chem. 2005, 280(6):4166-4173.
45. Welch H.C., Condliffe A.M., Milne L.J., Ferguson G.J., Hill K., Webb L.M., et al. P-Rex1 regulates neutrophil function. Curr. Biol. 2005, 15(20):1867-1873.
46. Khayat Z.A., Tong P., Yaworsky K., Bloch R.J., Klip A. Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes. J. Cell Sci. 2000, 113(Pt 2):279-290.
47. Kowluru A., Veluthakal R. Rho guanosine diphosphate-dissociation inhibitor plays a negative modulatory role in glucose-stimulated insulin secretion. Diabetes 2005, 54(12):3523-3529.
48. Das S.K., Chu W.S., Hale T.C., Wang X., Craig R.L., Shuldiner A.R., et al. Polymorphisms in the glucokinase-associated, dual-specificity phosphatase 12 (DUSP12) gene under chromosome 1q21 linkage peak are associated with type 2 diabetes. Diabetes 2006, 55(9):2631-2639.
49. Takeuchi F., Yanai K., Inomata H., Kuzuya N., Kajio H., Honjo S., et al. Search of type 2 diabetes susceptibility gene on chromosome 20q. Biochem. Biophys. Res. Commun. 2007, 357(4):1100-1106.